APRICUS BIOSCIENCES, INC. Note Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 8 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective July 16, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
2024
Amendment No. 7 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective June 1, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
2024
Amendment No. 6 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective May 1, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
2024
Amendment No. 5 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective March 27, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
2024
Amendment No. 4 to Convertible Promissory Note and Amendment to Letter Agreement, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective...
Note Agreements
APRICUS BIOSCIENCES, INC.
2023
Amendment No. 3 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated May 19, 2023
Note Agreements
APRICUS BIOSCIENCES, INC.
2023
Amendment No. 2 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated February 8, 2023
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated December 10, 2021
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Form of Convertible Promissory Note due November 23, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Form of Convertible Promissory Note due December 11, 2022
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Form of Seelos Therapeutics, Inc. Convertible Promissory Note
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2018
Form of Seelos Therapeutics, Inc. Note Purchase Agreement
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2018
AMENDED AND RESTATED 7% CONVERTIBLE NOTE DUE DECEMBER 31, 2014 OF APRICUS BIOSCIENCES, INC.
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2013
AMENDED AND RESTATED 7% CONVERTIBLE NOTE DUE DECEMBER 31, 2014 OF APRICUS BIOSCIENCES, INC.
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2013
AMENDED AND RESTATED 7% CONVERTIBLE NOTE DUE DECEMBER 31, 2014 OF APRICUS BIOSCIENCES, INC.
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2013
7% CONVERTIBLE NOTE DUE DECEMBER 31, 2011 OF NEXMED, INC. Note No.: ___ Original Principal Amount: ________ Issuance Date: June 27, 2008 New York, New York
Note Agreements
APRICUS BIOSCIENCES, INC.
2008
NEXMED, INC. 8.0% Senior Secured Note Due June 30, 2009
Note Agreements
APRICUS BIOSCIENCES, INC.
2007
NEXMED, INC. 7.5% Senior Secured Note Due December 31, 2007
Note Agreements
APRICUS BIOSCIENCES, INC.
2006